EP4448780A2 - Mélanges de glucose et de xylose pour la production fermentative d'acide ortho-aminobenzoïque - Google Patents

Mélanges de glucose et de xylose pour la production fermentative d'acide ortho-aminobenzoïque

Info

Publication number
EP4448780A2
EP4448780A2 EP22856984.4A EP22856984A EP4448780A2 EP 4448780 A2 EP4448780 A2 EP 4448780A2 EP 22856984 A EP22856984 A EP 22856984A EP 4448780 A2 EP4448780 A2 EP 4448780A2
Authority
EP
European Patent Office
Prior art keywords
xylose
glucose
weight
oab
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22856984.4A
Other languages
German (de)
English (en)
Inventor
Anja SPAETH
Frederik Walter
Cedric DAVOUDI
Wolf KLOECKNER
Lena SCHAFFERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covestro Deutschland AG
Original Assignee
Covestro Deutschland AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covestro Deutschland AG filed Critical Covestro Deutschland AG
Publication of EP4448780A2 publication Critical patent/EP4448780A2/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15—Corynebacterium

Definitions

  • the present invention relates to the production of ortho-aminobenzoic acid by microbial fermentation using mixtures of glucose and xylose as fermentable substrates.
  • ortho-aminobenzoic acid (oAB) using a number of genetically modified microorganisms is known from the prior art, for example from Balderas-Hernandez et al. (2009) "Metabolism engineering for improving anthranilate synthesis from glucose in Escherichia coli", WO 2015/124687 and WO 2017/102853.
  • WP 3061828 describes a process for the production of amino acids, in particular glutamic acid, by Corynebacterium. A release of oAB by these strains has not been described and was also not intended.
  • the present invention relates to a method containing the step of cultivating one or more microbial cells that can convert glucose and xylose to oAB in a nutrient medium that contains a mixture of glucose and xylose with a glucose content of between 5% by weight. % and 86% by weight and a xylose content between 95% by weight and 14% by weight, the proportions of glucose and xylose adding up to 100% and oAB being produced.
  • a nutrient medium that contains a mixture of glucose and xylose with a glucose content of between 5% by weight. % and 86% by weight and a xylose content between 95% by weight and 14% by weight, the proportions of glucose and xylose adding up to 100% and oAB being produced.
  • the metabolic pathways in the microbial cell are segregated such that xylose is used exclusively to form oAB while growth occurs on glucose. A product formation from glucose is not excluded here.
  • the metabolic pathways in the microbial cell are segregated such that glucose is used exclusively to form oAB while growth occurs on xylose. A product formation from xylose is not excluded here.
  • At least 0.09 grams of oAB are formed per gram of glucose and xylose consumed by the at least one microbial cell during incubation. This corresponds to a carbon yield of at least 0.138 moles of carbon in the form of oAB per mole of carbon consumed in glucose and xylose. Under particularly favorable conditions, these values can be at least 0.1 g oAB per gram of glucose and xylose consumed, which corresponds to a carbon yield of at least 0.153 moles of carbon in oAB per mole of carbon in glucose and xylose.
  • oAB refers to ortho-aminobenzoic acid, also known as "anthranilic acid". Since this compound has both a carboxyl group with acidic properties and an amino group with basic properties, the charge on the molecule depends on the pH In the present application, the term “ortho-aminobenzoic acid” refers to the molecule regardless of whether it has a net positive, negative or no net charge.
  • Nutrient media which are suitable for cultivating microbial cells, in particular Corynebacterium, are known from the prior art.
  • Suitable nutrient media contain at least one buffer for regulating the pH, sources of inorganic nutrients that can be used by the microorganism used, in particular nitrogen, sulfur and phosphorus, and the trace elements required by the organism used.
  • sources of inorganic nutrients that can be used by the microorganism used, in particular nitrogen, sulfur and phosphorus, and the trace elements required by the organism used.
  • the addition of vitamins and/or complex media components such as peptone or yeast extract can be useful.
  • Particularly suitable nutrient media are described in the exemplary embodiments contained in this application.
  • the nutrient medium must contain glucose and xylose, with the glucose content being between 5% and 86% by weight and the xylose content being between 95% and 14% by weight, and the proportions of glucose and xylose being 100 Add % as a source of energy and carbon for the microorganism. This serves both to build up biomass and to form oAB. The presence of other energy and carbon sources is not excluded. However, it is preferred that the mass fraction of the sum of xylose and glucose in the total amount of sugars present in the nutrient medium is at least 70% by weight, preferably at least 80% by weight and particularly preferably at least 90% by weight.
  • At least one sugar selected from the group consisting of galactose, sucrose, arabinose, cellobiose, maltose and fructose is present in the nutrient medium while maintaining the above-defined total proportions of glucose and xylose.
  • the nutrient medium in this embodiment can also contain lactic acid and/or acetic acid.
  • the mass fraction of the sum of xylose and glucose in the total amount of all energy and carbon sources present in the nutrient medium that can be used by the microorganism is at least 70% by weight, preferably at least 80% by weight and particularly preferably at least 90% by weight.
  • energy source and “carbon source” are known to those skilled in the art. In the context of heterotrophic microorganisms, they describe those organic carbon compounds from which the microorganism in question can either obtain the energy required for its metabolism or which it can use to build up biomass.
  • the proportion of glucose in the mixture of glucose and xylose is preferably 5% by weight to 86% by weight, more preferably 8% by weight to 86% by weight, even more preferably 12% by weight to 86% by weight. -% and most preferably 16% to 86% by weight, with xylose contributing the balance in each case to 100% by weight.
  • the yield a distinction is made according to the invention between two values, the substrate yield and the process yield.
  • substrate yield the amount of oAB produced is related to the amount of glucose and xylose consumed by the microbial cells during cultivation. Residual amounts of glucose and xylose that were added to the nutrient medium but are still present in the nutrient medium at the end of the cultivation are not taken into account.
  • the amount of oAB produced is related to the amount of glucose and xylose added to the nutrient medium during cultivation, regardless of whether these substrates have been completely converted or are still present as residual amounts in the nutrient medium. To put it simply, unused amounts of glucose and xylose are recorded as losses in the process yield by the microbial cells at the end of the cultivation.
  • the proportion of glucose in the mixture of glucose and xylose is 40% by weight to 86% by weight, preferably 50% by weight to 86% by weight preferably from 60% to 86% by weight, and even more preferably from 63% to 86% by weight, with xylose contributing the missing portion to 100% by weight.
  • the term “cultivation” refers to the incubation of one or more microbial cells in the nutrient medium described above under conditions that enable the metabolic activity of the cells. This means in particular the setting and maintenance of a suitable pH value, a suitable oxygen saturation, a suitable temperature and a suitable osmolality.
  • the person skilled in the art can select cultivation conditions which are suitable for the microorganism in question on the basis of his specialist knowledge and the generally available literature.
  • the cultivation of Corynebacterium, in particular Corynebacterium glutamicum is preferably carried out at a pH between 6 and 8, at a temperature between 25° C and 40° C. and at an osmolality between 400 and 2600 mOsmol/kg
  • the oxygen saturation is preferably kept as close as possible to the maximum that can be achieved under standard pressure and standard atmosphere.
  • the metabolic activity preferably consists in the production of oAB and/or the build-up of biomass, particularly preferably in the production of oAB.
  • a suitable parameter that allows continuous monitoring of metabolic activity for process control is also the oxygen uptake rate. This can be done continuously, for example by oxygen electrodes, and delivers measurement results without a time delay that can be used to adapt the cultivation conditions.
  • the process of incubating at least one microbial cell in a nutrient medium described above under conditions that enable the formation of oAB by the microbial cells is also referred to below as “microbial fermentation”.
  • the microbial cell is preferably a heterotrophic bacterial cell, more preferably a bacterium from the genus Corynebacterium and most preferably Corynebacterium glutamicum.
  • the microbial cell is a Corynebacterium, preferably Corynebacterium glutamicum,
  • the present application relates to a strain of the genus Corynebacterium, preferably Corynebacterium glutamicum and particularly preferably Corynebacterium glutamicum ATCC13032, which differs from the wild type at least in the following characteristics:
  • the residual activity is preferably between 10% and 60%, more preferably between 20% and 50% of the activity natively present in C. glutamicum ATCC13032. This is preferably achieved by an expression of the gene for the anthranilate phosphoribosyltransferase (trpD) which is reduced compared to the wild type, although the expression is not completely suppressed.
  • the activity of the anthranilate phosphoribosyltransferase is reduced by deleting or inactivating the gene for the endogenous anthranilate phosphoribosyltransferase (trpD) and replacing this gene with a gene for an anthranilate phosphoribosyltransferase with a modified ribosomal binding site and optionally a modified start codon as in SEQ ID NO. 1 or 2, preferably SEQ. ID NO. 2 defined.
  • the amino acid sequence of the anthranilate phosphoribosyltransferase preferably corresponds to the endogenous anthranilate phosphoribosyltransferase, it is particularly preferably represented by SEQ ID NO. 3 or a variant thereof.
  • Increased activity of shikimate kinase This is preferably done by increased expression of a corresponding enzyme. In one embodiment of the present invention, the activity is increased by increased expression of the gene for the endogenously present shikimate kinase as in SEQ ID NO. 6 defined or a variant thereof. In another preferred embodiment, this is done by expressing an exogenous shikimate kinase, preferably as shown in SEQ. ID NO. 7 or a variant thereof.
  • Increased expression of a gene can be achieved by any of the methods known to those skilled in the art, in particular by introducing multiple copies of the relevant gene into the microorganism or by using stronger promoters to express the endogenously present enzyme.
  • a particularly preferred promoter for the expression of foreign genes or the increased expression of endogenous genes is P tuf as in SEQ ID NO. 8 defined.
  • DAHP synthase 3-deoxyarabinoheptulosanate-7-phosphate synthase
  • Preferred is an enzyme with the The amino acid sequence defined in SEQ ID NO.11 or a variant thereof.
  • xylose isomerase and xylulokinase Increased activity of xylose isomerase and xylulokinase.
  • This increased activity preferably occurs through increased expression of the two genes.
  • This increased expression can take place by any method known to the person skilled in the art, in particular by introducing several copies of the corresponding gene into the microorganism or by using stronger promoters for the expression of the endogenously present enzyme.
  • a xylose isomerase as in SEQ ID NO. 12 defined or a variant thereof.
  • the gene encoding the phosphoenolpyruvate carboxylase as in SEQ ID NO. 4 defined encoded, deleted or inactivated. This can be done in any way familiar to a person skilled in the art, preferably by deleting the gene or a partial sequence thereof, by introducing at least one stop codon or by deleting or inactivating the promoter sequence.
  • the deletion of at least part of the protein-coding sequence of the gene (SEQ ID NO. 5) is particularly preferred.
  • shikimate kinase SEQ ID NO.
  • variant means an enzyme by addition, deletion or replacement of up to 10%, preferably up to 5%, of amino acids contained in the respective enzyme is obtained.
  • modifications can be carried out continuously or discontinuously at any desired point in the enzyme. However, they are preferably carried out only at the N terminus and/or at the C terminus of the polypeptide.
  • substitutions of amino acids are involved preferably conservative substitutions, ie those in which the altered amino acid has a residue with similar chemical properties to the amino acid present in the unmodified enzyme with also acidic residues, amino acids with polar residues exchanged for those with polar residues and amino acids with non-polar residues for those with non-polar residues.
  • the specific enzyme activity of a variant is preferably at least 80% of the specific activity of the unmodified enzyme. The person skilled in the art can find enzyme tests for detecting the activity of the aforementioned enzymes in the literature.
  • variant means an enzyme that is obtained by adding, deleting or replacing up to 5%, preferably up to 2%, of the amino acids contained in the respective enzyme provided that positions 76 and 211 remain unchanged It is further preferred that positions 10, 13, 147, 148, 150, 151, 179, 209, 211 and 212 also remain unchanged In a more preferred embodiment of the present invention According to the invention, positions 144, 175 and 215 are also unchanged in the variant. In an even more preferred embodiment of the present invention, in addition to the aforementioned positions, positions 92, 97, 165, 186 and 268 are also unchanged.
  • the aforementioned positions shift accordingly when amino acids are deleted or inserted
  • the aforementioned modifications can be carried out continuously or discontinuously at any desired point in the enzyme. However, they preferably occur only at the N-terminus and/or at the C-terminus of the polypeptide.
  • Amino acid substitutions are preferably conservative substitutions, ie those in which the altered amino acid has a residue with similar chemical properties to the amino acid present in the unmodified enzyme. It is therefore particularly preferred to exchange amino acids with basic residues for those with basic residues, amino acids with acidic residues for those with residues that are also acidic, amino acids with polar residues for those with polar residues and amino acids with non-polar residues for those with non-polar residues.
  • the variant of the DAHP synthase also has a corresponding enzyme activity.
  • the specific enzyme activity of the variant is particularly preferably at least 80% specific activity of the unmodified DAHP synthase according to SEQ ID NO. 11.
  • the present invention relates to the use of a nutrient medium which is a mixture of glucose and xylose with a glucose content of between 5% by weight and 86% by weight and a xylose content of between 95% by weight and 14% by weight. %, with the proportions of glucose and xylose adding up to 100%, for the production of oAB by microbial fermentation.
  • the cell is capable of releasing oAB into the nutrient medium and preferably also accumulating there.
  • enrichment means that oAB concentrations of at least 1 g/L, preferably at least 2 g/L, are achieved.
  • the present application relates to a cell of the genus Corynebacterium suitable for the release of oAB, preferably Corynebacterium glutamicum and particularly preferably Corynebacterium glutamicum ATCC13032, which differs from the wild type at least in the following characteristics:
  • the residual activity is preferably between 10% and 60%, more preferably between 20% and 50% of the activity natively present in C. glutamicum ATCC13032. This is preferably achieved by an expression of the gene for the anthranilate phosphoribosyltransferase (trpD) which is reduced compared to the wild type, although the expression is not completely suppressed.
  • the activity of the anthranilate phosphoribosyltransferase is reduced by deleting or inactivating the gene for the endogenous anthranilate phosphoribosyltransferase (trpD) and replacing this gene with a gene for an anthranilate phosphoribosyltransferase with a modified ribosomal binding site and optionally a modified start codon as in SEQ ID NO. 1 or 2, preferably SEQ. ID NO. 2 defined.
  • amino acid sequence of the anthranilate phosphoribosyltransferase preferably corresponds to the endogenous anthranilate phosphoribosyltransferase, it is particularly preferably represented by SEQ ID NO. 3 or a variant thereof.
  • DAHP synthase 3-deoxyarabinoheptulosanate-7-phosphate synthase
  • Preferred is an enzyme with the The amino acid sequence defined in SEQ ID NO.11 or a variant thereof.
  • xylose isomerase and xylulokinase Increased activity of xylose isomerase and xylulokinase.
  • This increased activity preferably occurs through increased expression of the two genes.
  • This increased expression can take place by any method known to the person skilled in the art, in particular by introducing several copies of the corresponding gene into the microorganism or by using stronger promoters for the expression of the endogenously present enzyme.
  • a xylose isomerase as in SEQ ID NO. 12 defined or a variant thereof.
  • the gene encoding the phosphoenolpyruvate carboxylase as in SEQ ID NO. 4 defined encoded, deleted or inactivated. This can be done in any way familiar to a person skilled in the art, preferably by deleting the gene or a partial sequence thereof, by introducing at least one stop codon or by deleting or inactivating the promoter sequence. The deletion of at least part of the protein-coding sequence of the gene (SEQ ID NO. 5) is particularly preferred. All definitions given earlier in this application also apply to this embodiment. This applies in particular to the genetic and metabolic properties of the cell.
  • the present invention relates to the use of a microbial cell differing from the wild type in the characteristics defined above in this application for the production of oAB by a microbial fermentation with a mixture of glucose and xylose as an energy and carbon source.
  • the present invention relates to a composition containing a) microbial cells which are suitable for the release of oAB and which can convert glucose and xylose to oAB; b) a mixture of glucose and xylose with a glucose content of between 5% by weight and 86% by weight and a xylose content of between 95% by weight and 14% by weight, the proportions of glucose and xylose being 100% add; and c) at least one source of nitrogen, at least one source of phosphorus, at least one source of sulfur and trace elements.
  • composition according to the invention is a nutrient medium in which the microbial cells are contained, so that only the incubation conditions described above have to be maintained for the microbial cells to convert the glucose and xylose contained into oAB.
  • the composition defined above when used as intended, the microbial cells contained therein produce oAB. Therefore, in a preferred embodiment of the present invention, the composition additionally contains oAB. More preferably it contains at least 1.5 g/L oAB.
  • Example 3 All experiments except those in Example 3 were performed on the strain whose generation is described below.
  • a microbial strain capable of utilizing xylose as a carbon source for the production of anthranilic acid was generated.
  • the starting strain was first adapted to increasing anthranilic acid concentrations in the culture supernatant by means of adaptive laboratory evolution (ALE). This was then brought to the production of anthranilic acid by targeted chromosomal modifications.
  • ALE adaptive laboratory evolution
  • the strain was then equipped with genes of the so-called xylose isomerase pathway, since C. glutamicum ATCC13032 does not have a native metabolic pathway for the utilization of xylose. All genetic modifications, i.e.
  • chromosomal deletions and integration of genes were carried out by double homologous recombination using corresponding pK19mobsacB derivatives (Schäfer et al., 1994: "Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum.” Gene 145(l):69-73. doi: 10.1016/0378-1119(94)90324-7)
  • TrpD The activity of the anthranilate phosphoribosyltransferase TrpD was reduced by first deleting the native trpD-A ⁇ e ⁇ and replacing it with an allele (called trpD5) with a GTG instead of ATG start codon and a ribosome binding site with a reduced distance to the start codon (SEQ ID NO. 1 ).
  • the gene (SEQ ID NO. 5) which encodes one or the only phosphoenolpyruvate carboxylase in C. glutamicum (SEQ ID NO. 4) was deleted.
  • an artificial, polycistronic P tuf -aroLAC operon consisting of the genes aroL (b0388) from Escherichia coli and aroA (cg0873) and aroC (cg1829) from C. glutamicum, under the control of the constitutive promoter of the elongation factor Tuf, integrated downstream from cg2563.
  • the allele aroG new which encodes a feedback-resistant variant of the DAHP synthase (SEQ ID NO. 11) from E. coli, was integrated downstream from cg3132 into the genome of the strain.
  • a synthetic construct consisting of a codon-optimized xylose isomerase gene xylA (xccl758) from Xanthomonas campestris pv. campestris (amino acid sequence of the enzyme according to SEQ ID NO. 13) , and the xylulokinase gene xylB (cg0147) from C. glutamicum (amino acid sequence of the enzyme according to SEQ ID NO. 14), each under the control of the P tuf promoter sequence (SEQ ID NO. 8) and followed by a rrnB terminator E.
  • Comparative cultivations of the above strain for the production of ortho-aminobenzoic acid were carried out starting from two different sugars in four different ratios to each other.
  • the main culture media were prepared in such a way that the two sugars, ⁇ -glucose and ⁇ -xylose, were present in amounts as shown in Table 1, based on the total sugar content of 20 g/L.
  • Table 1 Overview of the compositions of the two different sugars ⁇ -glucose and ⁇ -xylose in the main cultivation media. Four replicates each with an initial cultivation volume of 50 mL were set up for media 1-4 and thus for each sugar quantity ratio.
  • Table 2 Overview of the cultivation conditions of the preliminary and main cultures. Erlenmeyer flasks with a maximum capacity of 500 mL each were used for incubating the second precultures (25 mL each), and Erlenmeyer flasks with a maximum capacity of 1000 mL each were used for incubating the main cultures (50 mL each before the first sampling). mL. Cotton plugs served as a sterile barrier. Media used, their composition and production
  • Table 3 Liquid and solid complex media from Brain Heart Infusion (BHI) for growing cells.
  • Table 4 Liquid minimal medium with complex components for growing cells in the preculture. The amounts weighed in are given for 1 L of ready-to-use CGXII preculture medium. After all reagents have been supplemented in the medium, the final target concentrations are achieved in the finished medium.
  • Table 5 Liquid minimal medium for the main culture. The amounts weighed in are given for 1 L of ready-to-use CGXII main culture medium. After all reagents have been supplemented in the medium, the final target concentrations are achieved in the finished medium. Devices used
  • the agar plate culture thus prepared was used to inoculate a BH I liquid culture.
  • some cell mass was removed from the respective BHI agar plate cultures and inoculated with 4 mL of BHI liquid medium in a round-bottom tube.
  • the liquid cultures were incubated for about 7.5 h at 30° C. and 200 rpm (preculture I).
  • CGXII preculture medium was prepared with either 20 g/L ⁇ -glucose or with 20 g/L ⁇ -glucose and additionally 10 g/L ⁇ -xylose.
  • 23 mL of the corresponding preculture medium were transferred to a 500 mL Erlenmeyer flask, 2 mL of the BHI liquid preculture I were added to both batches and these two shake flask precultures were incubated at 200 rpm and 30 °C for 17 h.
  • the preculture with ⁇ -glucose as sole energy and carbon source was used for the inoculation of the main cultures with Medium 1.
  • the preculture with 20 g/L ⁇ -glucose and additionally 10 g/L ⁇ -xylose three different main cultures (media 2-4) were inoculated.
  • the optical density of the cultures was measured. Depending on the cell density achieved, a portion of these second precultures was removed, the cells pelleted by centrifugation, washed in sterile phosphate buffer (single-concentration) and resuspended in 50 mL of the corresponding main culture medium (media 1-4).
  • Table 14 Measurement of the optical density (OD 600 ) after incubation of the second preculture in the shake flask has taken place. Based on this, it was calculated how much volume of the second preculture is required to inoculate 50 mL of the main culture with an initial OD 600 of 1. Four replicates were created per medium. Since three media containing xylose (media 2-4) were to be tested, a total of 12 aliquots for inoculation were taken from the preculture with 20 g/L D-glucose and 10 g/L D-xylose.
  • the main cultures prepared in this way were transferred to a Kuehner incubator shaker (Table 13) and incubated.
  • the shake flasks were removed from the incubator shaker and weighed to determine evaporation effects. Samples were taken under sterile conditions for the determination of glucose, xylose, ortho-aminobenzoic acid and dry biomass.
  • Table 15 Overview of the ⁇ -xylose concentrations over time for four replicates each with medium 1 and medium 2. ⁇ -xylose concentration
  • Table 17 Overview of the ⁇ -glucose concentrations over time for four replicates each with medium 1 and medium 2. ⁇ -glucose concentration
  • Table 18 Overview of the ⁇ -glucose concentrations over time for four replicates each with medium 3 and medium 4.
  • Table 22 Overview of the ortho-aminobenzoic acid concentration over time for four replicates each with medium 3 and medium 4.
  • Table 23 Overview of the ortho-aminobenzoic acid yields after 66.50 h for four replicates with medium 1 and medium 2. These are given as mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ) , whereby on the one hand the metabolized carbon source and on the other hand the carbon source present in the medium is included in the calculation.
  • Table 24 Overview of the ortho-aminobenzoic acid yields after 66.50 h for four replicates with medium 3 and medium 4. These are given as mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ) , whereby on the one hand the metabolized carbon source and on the other hand the carbon source present in the medium is included in the calculation.
  • Table 25 Overview of the mean values and standard deviations of the ortho-aminobenzoic acid yields from four replicates each after 66.50 h. These are given as a mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ), whereby the metabolized carbon source and the carbon source present in the medium are included in the calculation.
  • the xylose was not completely consumed by the end of the cultivation, which is why the final product yield varies between the "substrate yield” based on the mass or amount of substance of the substrate consumed (g oAb / g consumed C source or mol oAb / g consumed C source ) and the "process yield” based on the mass or amount of substance of the submitted substrate (g oAb / g submitted C source or mol oAb / mol submitted C source ).
  • the substrate yield was found to be highest using Medium 2 at 0.106 g oAb /g C source consumed and 0.129 mol oAb /mol C source consumed , respectively.
  • the achieved biodry matter concentration decreased with increasing xylose content.
  • Comparative cultivations of the above-described strain for the production of ortho-aminobenzoic acid were carried out starting from two different sugars in eight different ratios.
  • the main culture media were prepared in such a way that the two sugars, ⁇ -glucose and ⁇ -xylose, were present in amounts as shown in Table 26, based on the total sugar content of 20 g/L.
  • Table 26 Overview of the compositions of the various sugars in the main cultivation media used.
  • Table 27 Settings on the BioLector Pro for the cultivation of the 48 microtiter plate.
  • Table 28 Layout of the M2P-MTP-48-BOH2 cultivation plate. The same volume of 1 mL of the main culture was used at each position.
  • Table 30 Liquid minimal medium with complex components for the cultivation of cells in the preculture. The amounts weighed in are given for 1 L of ready-to-use CGXII preculture medium. After all reagents have been supplemented in the medium, the final target concentrations are achieved in the finished medium.
  • Table 31 Liquid minimal medium for the main culture. The amounts weighed in are given for 1 L of ready-to-use CGXII main culture medium. After all reagents have been supplemented in the medium, the final target concentrations are achieved in the finished medium.
  • Table 39 Overview of the parameters examined in this study as well as the devices and methods for their examination.
  • Table 40 Overview of the products from Beckman Coulter GmbH used for cultivating the main cultures.
  • the agar plate culture thus prepared was used to inoculate a BH I liquid culture.
  • some cell mass was removed from the BHI agar plate culture and 4 mL BHI liquid medium was inoculated into a round-bottom tube.
  • the liquid culture was incubated for about 7.5 hours at 30° C. and 200 rpm (preculture I).
  • CGXII preculture medium was prepared with either 20 g/L ⁇ -glucose or with 20 g/L ⁇ -glucose and additionally 10 g/L ⁇ -xylose and 50 mL each was transferred to a 1 L Erlenmeyer flask. 2 mL of the BHI liquid preculture were added to both batches and these two shake flask precultures were incubated at 200 rpm and 30 °C for 17 h.
  • the optical density of the cultures which had either only glucose or a mixture of glucose and xylose available as the carbon source, was measured. Depending on the cell density achieved, a portion of these second precultures was removed, the cells pelleted by centrifugation, washed in sterile phosphate buffer (single-concentration) and resuspended in the appropriate main culture medium (media 1-8).
  • Table 41 Measurement of the optical density (OD 600 ) after incubation of the second preculture in the shake flask has taken place. Based on the measured optical density, it was calculated how much volume of the second preculture is needed to inoculate 10 mL of the main culture with an initial OD 600 of 1. Since media containing xylose were to be tested with seven different xylose concentrations, seven aliquots for the inoculation were taken from the preculture with 20 g/L ⁇ -glucose and 10 g/L ⁇ -xylose.
  • the preculture with glucose as sole carbon and energy source was used for the preparation of the main medium 1 culture.
  • the main cultures were inoculated with media 2-8 using the preculture with glucose and xylose. From the main cultures produced in this way, 6 x 1 mL each (6 replicates per sugar quantity ratio) were placed in different positions Pipette the cultivation plate, seal the cultivation plate with foil and transfer it to the BioLector Pro.
  • Table 42 Overview of the ⁇ -xylose concentrations for the six replicates with medium 1 and medium 2 at the beginning of the cultivation and after 70.79 h. ⁇ -xylose concentration
  • Table 43 Overview of the ⁇ -xylose concentrations for the six replicates with medium 3 and medium 4 at the beginning of the cultivation and after 70.79 h. ⁇ -xylose concentration
  • Table 44 Overview of the ⁇ -xylose concentrations for the six replicates with medium 1 and medium 2 at the beginning of the cultivation and after 70.79 h. ⁇ -xylose concentration
  • Table 45 Overview of the ⁇ -xylose concentrations for the six replicates with medium 7 and medium 8 at the beginning of the cultivation and after 70.79 h.
  • Table 46 Overview of the ⁇ -glucose concentrations for the six replicates with medium 1 and medium 2 at the beginning of the cultivation and after 70.79 h. ⁇ -glucose concentration
  • Table 47 Overview of the ⁇ -glucose concentrations for the six replicates with medium 3 and medium 4 at the beginning of the cultivation and after 70.79 h.
  • Table 48 Overview of the ⁇ -glucose concentrations for the six replicates with medium 5 and medium 6 at the beginning of the cultivation and after 70.79 h. ⁇ -glucose concentration
  • Table 49 Overview of the ⁇ -glucose concentrations for the six replicates with medium 7 and medium 8 at the beginning of the cultivation and after 70.79 h.
  • Table 50 Overview of the dry matter concentrations for the six replicates with medium 1 and medium 2 after 70.79 h.
  • Table 51 Overview of the biodry matter concentrations for the six replicates with medium 3 and medium 4 after 70.79 h.
  • Table 52 Overview of the biodry matter concentrations for the six replicates with medium 5 and medium 6 after 70.79 h.
  • Table 54 Overview of the ortho-aminobenzoic acid concentration for the six replicates with medium 1 and medium 2 after 70.79 h. ortho-aminobenzoic acid concentration (oAB)
  • Table 55 Overview of the ortho-aminobenzoic acid concentration for the six replicates with medium 3 and medium 4 after 70.79 h. ortho-aminobenzoic acid concentration (oAB)
  • Table 56 Overview of the ortho-aminobenzoic acid concentration for the six replicates with medium 5 and medium 6 after 70.79 h. ortho-aminobenzoic acid concentration (oAB)
  • Table 58 Summary of ortho-aminobenzoic acid yields after 70.79 h for six replicates with
  • Medium 1 and medium 2 These are given as a mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ), whereby the metabolized carbon source and the carbon source present in the medium are included in the calculation becomes.
  • Table 59 Overview of the ortho-aminobenzoic acid yields after 70.79 h for six replicates with medium 3 and medium 4. These are given as mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ) , whereby on the one hand the metabolized carbon source and on the other hand the carbon source present in the medium is included in the calculation.
  • Table 60 Overview of the ortho-aminobenzoic acid yields after 70.79 h for six replicates with medium 5 and medium 6. These are given as mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ) , whereby on the one hand the metabolized carbon source and on the other hand the carbon source present in the medium is included in the calculation.
  • Table 61 Overview of the ortho-aminobenzoic acid yields after 70.79 h for six replicates with medium 7 and medium 8. These are given as mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ) , whereby on the one hand the metabolized carbon source and on the other hand the carbon source present in the medium is included in the calculation.
  • Table 62 Overview of the mean values and standard deviations of the ortho
  • the xylose was not completely consumed by the end of the cultivation, which is why the final product yield varies between the "substrate yield” based on the mass or amount of substance of the substrate consumed (g oAb / g consumed C source or mol oAb / mol consumed C source ) and the "process yield” based on the mass or amount of substance of the submitted substrate (g oAb / g submitted C source or mol oAb / mol submitted C source ).
  • the media used in this example 3 can be found in Tables 3 to 12 or Tables 29 to 38 and Table 63.
  • the cultivation parameters corresponded to those from Table 27, the cultivation time in Example 3 being 70.95 h.
  • Example 3 Except for the measurement of the dry biomass, the parameters from Table 39 were analyzed in Example 3 using the devices from Table 39 and the devices in Table 40 were used for the cultivation.
  • the agar plate culture thus prepared was used to inoculate an SY liquid culture. For this purpose, some cell mass was removed from the BHI agar plate culture and 4 mL SY- Liquid medium inoculated in a round bottom tube. The liquid culture was incubated for about 7.5 hours at 30° C. and 200 rpm (preculture I).
  • CGXII preculture medium was prepared with 15 g/L ⁇ -glucose and 5 g/L ⁇ -xylose and 24 mL each was transferred to two 500 mL Erlenmeyer flasks. 1 mL of the SY liquid preculture was added to both batches and these two shake flask precultures were incubated at 200 rpm and 30 °C for 17 h.
  • the optical density of the cultures which had a mixture of glucose and xylose available as the carbon source was measured. Depending on the cell density achieved, a portion of these second precultures was removed, the cells were pelleted by centrifugation, washed in sterile phosphate buffer (single concentration) and resuspended in the appropriate main culture medium.
  • Table 64 Measurement of the optical density (OD 600 ) in duplicate after incubation of the second precultures in the shake flask has taken place. Based on the mean values of the measured optical density, it was calculated how much volume of the second preculture is required to inoculate 25 mL main cultures of C. glutamicum Gizmo and C. glutamicum Geronimo with an initial OD 600 of 1.
  • Table 65 Overview of the ⁇ -xylose concentrations at the beginning and end of cultivation for three replicates each of C. glutamicum Gizmo and C. glutamicum Geronimo.
  • the medium contained an initial sugar content of 76% by weight of ⁇ -glucose and 24% by weight of ⁇ -xylose, based on the total sugar.
  • the initial ⁇ -xylose concentration was determined in the uninoculated main culture medium.
  • Table 66 Overview of the ⁇ -glucose concentrations at the beginning and end of the cultivation for three replicates each of C. glutamicum Gizmo and C. glutamicum Geronimo.
  • the medium contained an initial sugar content of 76% by weight of ⁇ -glucose and 24% by weight of ⁇ -xylose, based on the total sugar.
  • the initial ⁇ -glucose concentration was determined in the uninoculated main culture medium.
  • Table 67 Overview of the ortho-aminobenzoic acid concentrations (oAb) at the beginning and end of cultivation for three replicates each of C. glutamicum Gizmo and C. glutamicum Geronimo.
  • the medium contained an initial sugar content of 76% by weight of ⁇ -glucose and 24% by weight of ⁇ -xylose, based on the total sugar.
  • Table 68 Overview of the ortho-aminobenzoic acid yields after 70.95 h for three replicates each of C. glutamicum Gizmo and C. glutamicum Geronimo in medium with an initial sugar content of 74% by weight ⁇ - glucose and 26% by weight ⁇ - Xylose related to total sugar. These are given as a mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ), whereby the metabolized carbon source and the carbon source present in the medium are included in the calculation.
  • g oAb /g C-source mass-related
  • mol oAb /mol C-source substance-amount-related quotient
  • Table 69 Overview of the mean values and standard deviations of the ortho-aminobenzoic acid yields from three replicates each of C. glutamicum Gizmo and C. glutamicum Geronimo in medium with initial sugar contents of 74% by weight ⁇ -glucose and 26% by weight ⁇ -xylose based on the total sugar after 70.95 h. These are given as a mass-related (g oAb /g C-source ) and substance-amount-related quotient (mol oAb /mol C-source ), whereby the metabolized carbon source and the carbon source present in the medium are included in the calculation.
  • g oAb /g C-source mass-related
  • mol oAb /mol C-source substance-amount-related quotient
  • Example 3 shows that the use of the two different variants of xylose isomerase does not lead to any relevant differences in the performance of the strains. Both variants are therefore equivalent in the context of the present invention.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne la production d'acide ortho-aminobenzoïque par fermentation microbienne, des mélanges de glucose et de xylose étant utilisés comme substrats fermentescibles.
EP22856984.4A 2021-12-17 2022-12-14 Mélanges de glucose et de xylose pour la production fermentative d'acide ortho-aminobenzoïque Pending EP4448780A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21215759.8A EP4198137A1 (fr) 2021-12-17 2021-12-17 Mélanges de glucose et de xylose destinés à la production fermentative d'acide ortho-aminobenzoïque
PCT/EP2022/085917 WO2023111053A2 (fr) 2021-12-17 2022-12-14 Mélanges de glucose et de xylose pour la production fermentative d'acide ortho-aminobenzoïque

Publications (1)

Publication Number Publication Date
EP4448780A2 true EP4448780A2 (fr) 2024-10-23

Family

ID=80113530

Family Applications (2)

Application Number Title Priority Date Filing Date
EP21215759.8A Withdrawn EP4198137A1 (fr) 2021-12-17 2021-12-17 Mélanges de glucose et de xylose destinés à la production fermentative d'acide ortho-aminobenzoïque
EP22856984.4A Pending EP4448780A2 (fr) 2021-12-17 2022-12-14 Mélanges de glucose et de xylose pour la production fermentative d'acide ortho-aminobenzoïque

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP21215759.8A Withdrawn EP4198137A1 (fr) 2021-12-17 2021-12-17 Mélanges de glucose et de xylose destinés à la production fermentative d'acide ortho-aminobenzoïque

Country Status (5)

Country Link
US (1) US20260117268A1 (fr)
EP (2) EP4198137A1 (fr)
CN (1) CN118525102A (fr)
CA (1) CA3236774A1 (fr)
WO (1) WO2023111053A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025132393A1 (fr) 2023-12-19 2025-06-26 Covestro Deutschland Ag Préparation d'acide aminobenzoïque

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6519476B2 (ja) * 2013-10-23 2019-05-29 味の素株式会社 目的物質の製造法
TW201546275A (zh) 2014-02-20 2015-12-16 拜耳材料科學股份有限公司 生產鄰－胺基苯甲酸鹽之重組菌株及來自經由２－胺基苯甲酸之再生資源發酵生產苯胺
ES2965637T3 (es) 2015-12-18 2024-04-16 Covestro Intellectual Property Gmbh & Co Kg Procedimiento para la producción de ácido orto-aminobenzoico y/o anilina mediante levadura recombinante

Also Published As

Publication number Publication date
EP4198137A1 (fr) 2023-06-21
CA3236774A1 (fr) 2023-06-22
WO2023111053A2 (fr) 2023-06-22
WO2023111053A3 (fr) 2023-08-17
US20260117268A1 (en) 2026-04-30
CN118525102A (zh) 2024-08-20

Similar Documents

Publication Publication Date Title
EP2598646B1 (fr) Cellules et procédé de production de rhamnolipides
EP2421960B1 (fr) Cellules et méthodes pour la production d'acétone
DE112008000243B4 (de) Verfahren zur Herstellung eines Fermentationsproduktes aus Kohlenstoffquellen, die Glycerin enthalten, unter Verwendung von Corynebacteria
DE112009000453T5 (de) Vektor zur Transformation unter Verwendung von Transposons, durch den Vektor transformierte Mikroorganismen und Verfahren zum Herstellen von L-Lysin unter Verwendung derselben
EP1015621A2 (fr) Procede de preparation microbienne d'aminoacides de la famille de l'aspartate et/ou du glutamate et agents utilisables dans le cadre de l'application dudit procede
DE3128411A1 (de) Kulturstamm-mutante von esccherichia coli sowie verfahren zur herstellung von phenylalanin
DE69230180T2 (de) Neuartige hefestämme zur herstellung von xylitol
DE69833200T2 (de) Verfahren für die produktion von l-glutaminsäure mittels fermentation
DE10129711B4 (de) Verfahren zur fermentativen Herstellung von Pyruvat
EP2670836A1 (fr) Procédé de préparation de 2,3-butanediol par fermentation
DE3823451C2 (de) Rekombinante DNA, damit transformierte Mikrooganismen und Verwendung dieser Mikroorganismen zur Herstellung von L-Lysin mit Hilfe dieser Mikroorganismen
EP4448780A2 (fr) Mélanges de glucose et de xylose pour la production fermentative d'acide ortho-aminobenzoïque
EP0436886A1 (fr) Procédé de la production de L-isoleucine et micro-organismes propres à cela et ADN recombinant
EP1924694B1 (fr) Procede de production d'acides amines par des micro-organismes
EP4198123A1 (fr) 3-désoxyarabinoheptulosanate-7-phosphate synthase particulièrement approprié pour la production par fermentation de l'acide ortho-aminobenzoïque
DE102013216658A1 (de) Verfahren zur fermentativen Herstellung von C4-Produkten und dafür geeignete Mikroorganismenstämme
US9127323B2 (en) Isolated yeast strain having high xylose consumption rate and process for production of ethanol using the strain
DE3786578T2 (de) Biotin-Synthetase kodierendes Gen und dessen Verwendung.
EP3820999A1 (fr) D-xylose-déshydrogénase provenant de bactéries corynéformes et procédé de production de d-xylonate
DE10220234A1 (de) Verfahren sowie Mikroorganismen zur mikrobiellen Herstellung von Pyruvat aus Kohlenhydraten sowie Alkoholen
WO2004009828A1 (fr) Procede de fabrication biotechnologique d'acide citrique au moyen d'une levure genetiquement modifiee yarrowia lipolytica
DE112008003111B4 (de) Corynebakterien, die Glyzerin enthaltende Kohlenstoffquellen verwerten, und Verfahren zur Herstellung eines Fermentationsprodukts unter Verwendung derselben
DE102022119514A1 (de) Genetisch veränderte Zellen von Methylorubrum zur fermentativen Produktion von Glycolsäure und Milchsäure aus Cx-Verbindungen
EP4665859A1 (fr) Glycation d'acide aminobenzoïque afin d'améliorer l'efficacité de processus microbiens
DE3320653A1 (de) Fermentatives verfahren zur herstellung von l-leucin

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240717

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)